Clinical Trial Update: Anticholinergic Burden in Schizophrenia [NA]

View source ↗

Summary

Clinical trial update indicates that the study on anticholinergic burden in schizophrenia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delusional Disorder
• Psychotic Disorders
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: TERMINATED